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Abstract In addition to the major cyclophilin-like peptidyl-prolyl cisltrans isomerases (PPIases) of Escherichia coli an enzyme of very low relative 
molecular mass (10.1 kDa) was discovered in this organism which gave first indication of the existence of a novel family in this enzyme class [1994, 
FEBS Lett. 343, 65-691. In the present report we describe the chemically determined amino acid sequence of four peptides derived from the IO. 1 
kDa protein by the treatment with either cyanogen bromide or endoproteinase Lys-C. Together with a continuous run of 75 amino acids starting 
N-terminally, the sequence of the mature enzyme, 92 residues in length, was elucidated. Cloning and determination of the primary structure of a 
DNA fragment encoding this enzyme were also performed. Overexpression of the enzyme by using multicopies of plasmid pSEP38 in E. coli and 
detecting an enhanced PPIase activity attributed to the 10.1 kDa enzyme provided additional proof that the 92 amino acid protein was a PPIase. 
The enzyme was called parvulin (lat.: parvulus, very small). Homology analyses indicated that several parvulin-like proteins could be found in the 
database screened. To further elucidate the functional role of PPIases it might be of some importance that homologous proteins like the PrtM protein 
of Lactococcus lactis and the PrsA lipoprotein of Bacillus subtilis are known to be involved in the protein export and maturation machinery of the 
bacteria. 
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1. Introduction 
Presently peptidyl prolyl cisltrans isomerases (PPIases, EC 
5.2.1.8), the enzymes which catalyze the cisltrans isomerization 
in oligopeptides and certain conformational states of proteins, 
are subdivided into two different, sequence-unrelated families. 
Due to their specific interaction with cyclosporin A and FK506, 
these enzymes are termed cyclophilins (Cyp) and FK506 bind- 
ing proteins (FKBPs), respectively (for reviews see [l-3]). Dif- 
ferent PPIases are found with relative molecular masses rang- 
ing between 11.8 and 158 kDa. Usually the enzymes contain a 
conserved core region common to all PPIases of a family, with 
additional C- and N-terminal extensions bearing sequence mo- 
tifs of mainly unknown function. Particularly for cyclophilins, 
this core region was found to be highly conserved uring evolu- 
tion from bacteria to humans. 
However, separation of cellular homogenates by either gel 
filtration or continuous free flow electrophoresis gave rise to 
the assumption of additional PPIase enzymes being less sensi- 
tive to cyclosporin A and FK506 [l]. 
An example for the detection in E. coli of a PPIase resistant 
to nanomolar concentrations of both types of inhibitors is an 
enzyme with a molecular mass of 10,101 + 2 Da [4]. In addition, 
the N-terminal 21 amino acid residues of the enzyme did not 
show any similarity to other members of PPIase families. These 
21 amino acids comprise already about 25% of the total chain 
length of the novel enzyme. Therefore, the presence of sequence 
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portions involved in activity should have been highly probable. 
However, residues thought to be involved in the expression of 
catalytic activity and thus strongly conserved throughout all of 
the FKBPs and cyclophilins were missing. For this reason, the 
results were an important indication for the existence of a third 
family of PPIases. It may be a characteristic of PPIases that, 
with a few exceptions, members of the cyclophilin or FKBP 
protein family established by convincing sequence similarity 
were mostly found to express enzyme activity. One of the excep- 
tions in the FKBP family is the metal ion binding FKBP with 
a molecular mass of 22 kDa from E. coli [5,6] which failed to 
show PPIase activity [5] when assayed with the standard en- 
zyme test [7]. Although the predicted fold resembled that of 
FKBP12, only 7 out of 13 amino acid residues, strongly con- 
served in all of the other FKBPs, were fully retained in this 
protein. 
In cyclophilins the residues 53-57 (human Cypl8cy number- 
ing) were found throughout as FHR(IV) motif. In each case 
tested this sequence motif was connected with PPIase proper- 
ties of the respective protein in the standard PPIase assay men- 
tioned above. Under easy terms, a database search utilizing the 
amino acid sequence of the entire polypeptide chain of the 10.1 
kDa PPIase from E. coli may help to identify homologous 
proteins with putative PPIase function. 
In this study the complete sequence, overexpression and par- 
tial characterization of the secondary structure by CD spectros- 
copy of the 10.1 kDa PPIase, named as parvulin, is described. 
Sequence comparisons identified other possible parvulins 
which together may form a third class of PPIases different from 
FKBPs and cyclophilins. 
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2. Experimental 
2.1. Amino acid sequence analysis 
A sample of the purified protein was cleaved in 75% formic acid by 
addition of a small crystal of CNBr and incubation at 23°C for 24 h 
under nitrogen in the hark. The cleavage products were separated by 
reversed uhase HPLC on a C4 column (0.46 x 25 cm. Vvdac 214 Tp54. 
5 pm) u&g 0.1% trifluoroacetic acid (solvent A) and 70% acetoni‘trile 
in 0.1% trifluoroacetic acid (solvent B) in a gradient from 0 to 90% B 
in 60 min at a flow rate of 0.5 ml/min. Another sample of protein was 
cleaved with endoproteinase Lys-C (Boehringer Mannheim) at an en- 
zyme/substrate ratio of 1: 50 in 0.1 M ammonium hydrogen carbonate 
containing 2 M urea for 4 h at 25°C. The resulting peptides were 
separated by reversed phase HPLC on a Cl8 column (0.3 x 25 cm, 
Vydac 218 Tp54, 5 pm) using the same solvent system as above and a 
gradient of (t-60% B in 160 min at a flow rate of 0.25 ml/min. For 
cysteine determination, purified protein (100 pmol) was reduced with 
2-mercaptoethanol in 0.25 M Tris-buffer, pH 8.5, containing 6 M gua- 
nidine hydrochloride and 1 mM EDTA by incubation at 22°C for 2 h 
under argon in the dark and subsequently alkylated with 4-vinylpyrid- 
ine by incubation as above. The modified protein was desalted by 
reversed phase HPLC on a C4 column (0.3 x 5 cm, Nucleosil 300-5) at 
40°C using 0.1% trifluoroacetic acid (solvent A) and acetonitrile con- 
taining 0.08% trifluoroacetic acid (solvent B) in a gradient of l-70% B 
in 10 min at a flow rate of 1 ml/min. Amino acid sequences were 
determined using Applied Biosystems equences 470A and 476A ac- 
cording to the manufacturer’s instructions. 
2.2. Molecular cloning techniques, DNA sequence analysis and gene 
expression 
E. coli K-12 strain HB 101 was used for the amplification of the 
parvulin gene pawA, The host strain used for transformation with 
recombinant plasmid derived from the vector pUC18 (Pharmacia, 
Freiburg) was E. coli K-12 strain DH5a. 
Isolation of plasmid DNA was performed by the alkaline extraction 
procedure [8]. DNA fragments were extracted from agarose gel using 
the Sephaglas BandPrep Kit (Phannacia, Freiburg). E. coli cells were 
transformed with hybrid-plasmids as in [9]. 
The complete parvulin gene was amplified by PCR using chromoso- 
ma1 DNA of E. coli K-12 strain HBlOl and the following primers: 
5’-GCACGACGTATTACGATGGC-3’ and S’-CTGTTCTCTCTTA- 
CGCTTGTGTG-3’. The primers were purchased from Pharmacia 
(Freiburg). After an initial henaturation step (2 min at 94°C) 35 cycles 
were performed (1 min at 94°C 1 min at 52°C and 1 min at 72°C) and 
completed by a final elongation step at 72°C for 5 min. 
The vector pUC18 was digested with SmaI (Boehringer, Mannheim) 
and deuhosnhorvlated. The PCR fraaments were cloned into DUCI 8. 
The redombinan; plasmid pSEP38 was obtained with an insert bf 1,134 
bp. 
Sequencing was carried out with a T7 polymerase sequencing kit 
(Pharmacia, Freiburg) as described by the manufacturer. Both strands 
were sequenced using a pUC18-universal primer followed by the se- 
quence primers SP4 to SP6 and a pUC18 reverse primer followed by 
the sequence primers SPl to SP3. The composition of the primers were: 
SPl, 5’-GATCCAGCAGATTCGTTTGGGC-3‘; SP2, 5’-GTACCA- 
AGCCACTCCCTGACTG-3’; SP3, S-GGTGCTGTACCGCAACT- 
AATAGC-3’; SP4, 5’-GAGCAGGTAGGTAAGAAACTGCG-3’; 
SP5, 5’-GTCAGTCAGGGAGTGGCTGGTAC-3’, and SP6, S-CG- 
ACTGACTTGTTGTACCAG-3’. 
2.3. PuriJcation of overexpressed parvulin from E. coli 
An overnight culture (5 ml) of E. coli strain K-12 DH5& harbouring 
plasmid pSEP38 was used to inoculate several 11 portions LB broth 
medium (10 g bactotryptone, 5 g NaCl, 5 g yeast extract) in parallel. 
After growth to late logarithmic phase at 37°C one of the parallel 
cultures was treated with 1 mM isopropyl /?-n-thiogalactopyranoside 
(IPTG) to induce enhanced expression of the IacZ promoted parvulin. 
Cells were harvested and treated as described [4]. The enzymatic assay 
for parvulin was performed as described [4]. The last step of the purifi- 
cation procedure (cation-exchange chromatography on a Fractogel 
EMD SO1--650(M) column) was omitted. For amino acid seauence 
analysis and elect&pray mass spectroscopy the protein was apphed to 
a C4 narrowbore reversed-phase HPLC column (50 x 3 mm, Nucleosil 
300-5, Macherey-Nagel (Diiren)) and eluted with a gradient of 0 to 60% 
acetonitrile in 0.1% aqueous trifluoroacetic acid within 12 min at a flow- 
rate of 1 mYmin. 
2.4. Protein analytical methods 
The molecular mass of the recombinant protein was determined by 
electrospray mass spectrometry as described [4]. 
SDS-PAGE was performed as in [4]. For Western immunoblotting 
the semi-dry electroblotting system Fast Blot B32 from Biometra 
(Giittingen) was used. A polyclonal antiserum specific to the 10.1 kDa 
PPIase was obtained from rabbit. HPLC purified protein (600 pg) was 
taken for immunisation using established procedures (pab productions, 
Hebertshausen). 
Circular dichroism was measured on a JASCO J-710 spectrophotom- 
eter (Jasco, Tokyo) with the protein dialysed against 10 mM sodium 
phosphate, pH 6.5. The resulting spectra were the average of 8 scans, 
recorded in a 0.1 cm cell at 20°C. For subtraction of the buffer baseline 
and smoothing the resulting spectrum we used the software provided 
by JASCO (Tokyo). 
2.5. Computer methods 
Database searches were performed using the UWGCG (University 
of Wisconsin Genetics Computer Group) and PIR (Protein Identifica- 
tion Resource) program packages. The FASTA and TFASTA algo- 
rithms [lo] were used for similarity searches. Multiple sequence 
alignments were generated using CLUSTAL [I I], pairwise similarity 
comparisons were performed using BESTFIT. 
3. Results and discussion 
The N-terminal amino acid sequence analysis of the PPIase 
yielded the first 75 amino acids of the protein (Fig. 1). This 
revealed the presence of a single methionine which was subse- 
quently used to generate peptide fragments by CNBr treatment. 
The resulting two fragments could be separated by reversed 
phase HPLC on a C4 column and showed the expected N- 
terminal sequences. However, it was not possible to sequence 
the complete C-terminal fragment because of the presence of 
some unfavourable bonds. Therefore, the protein was also 
cleaved with endoproteinase Lys-C and the peptides were sep- 
arated by Cl8 reversed phase HPLC. Screening of the major 
peaks yielded among others the C-terminal peptides Kl and 
K2, completing the sequence (Fig. 1). At this stage the sequence 
still contained two unidentified amino acid residues at positions 
41 and 69. The difference in mass between the measured value 
and the sum of identified residues was 206 Da, indicating the 
presence of cysteine residues at these positions. Final proof for 
this assignment was obtained by treating the protein with 
4-vinylpyridine. The mass difference between modified and 
unmodified protein was found to be 210 Da, corresponding 
exactly to two pyridylethyl residues. The calculated relative 
molecular mass of 10,100.44 Da for the 92 amino acid-long 
sequence was in excellent agreement with the value of 
2 AKYAAALHILVKEEKLALDLLEG~KNGADFGKLAKKNSIc 
~___._______.___.__.____..._______._ N-Yen ____._____-.___________________.__. 
I______._._______._________________ CG2 ___________-________________) 
42 PSGKRCGDLCEFRQGQWVPAFDKYVfSCPVLEPTGPLNTG 
_______-.___-----.__________-.___-----___-~---~_________-.___-______-, 
~._____-___________ CG, ____.______.._____.____ 
02 FGYNI IKVLYRN 
I- K1 -I:- K2 --I 
_--______--.---.._, 
Fig. 1. The sequence of mature parvulin as derived from N-terminal 
sequence analysis (N-Term) and sequence analyses of peptides gener- 
ated by cleavage with CNBr (CB) and endoproteinase Lys-C (K). Only 
K-peptides important for sequence determination are shown. The cys- 
teines were determined by mass spectrometry of the unmodified and the 
pyridylethylated protein. Amino acid residues were numbered accord- 
ing to the gene sequence (Fig. 2). 
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10,101.3 f. 2 Da determined previously by electrospray mass 
spectrometry [4]. The protein sequence was then backtranslated 
into a DNA sequence using the coding preference of E. coli. 
Searching the GenEMBL database with this DNA sequence 
using the TFASTA program identified a region between 84.5 
to 86.5 min in the E. coli genome [12] which contained this 
previously uncharacterized sequence. However, the open read- 
ing frame contained two frameshift errors due to the lack of 
cytosines after bases 12,717 and 12,776. When this was cor- 
rected, the identity was 100% except for the starting Met which 
was not present in the mature protein. For resequencing of this 
region a 1,134 bp fragment was isolated by the PCR method 
using primers corresponding to the region of 12,370 to 12,390 
and 12,482 to 12,501 of the E. coli sequence locus ECOUWSSU. 
Both strands of the 1,134 bp fragment were sequenced after 
cloning into the pUCl8 vector using the &a1 restriction site 
and the transformation of competent E. cob K-12 DHSa eels 
(Fig. 2). 
This construct was also used for recombinant production of 
parvulin in order to ascertain that the polypeptide chain of 
Fig. 2. Nucleotide and deduced amino acid sequence of theparr, gene 
and the neighbouring regions. Nucleotides and amino acids are num- 
bered on the left hand side. The potential ribosome binding site (rbs) 
is underlined. A possible promoter sequence (indicated by -35 and -10) 
is underlined and printed in italics. Two putative terminator egions are 
indicated by two arrows. 
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Fig. 3. Western immunoblot analysis of proteins from E. coli K-12 cells. 
The immunoblot was performed after running an SDS-PAGE (17.5%). 
Lane 1, strain DH5a with pSEP38, 0.5 pg protein; lane 2, HBIOI, 0.5 
fig protein. 
92 amino acids did indeed contain the full information neces- 
sary for the catalytic machinery of a PPIase. 
In fact, as monitored by Western blot experiments the 
amount of the protein was significantly enhanced in the trans- 
formed cells (Fig. 3). However, IPTG induced expression did 
not lead to a further enhancement of the protein yield, indicat- 
ing that the used construct already contained a promoter read 
with maximal efficiency. In order to confirm that the observed 
higher yield of the protein lead to an increased PPIase activity 
as well, purification and enzymatic assay of the wild-type E. coli 
and the transformed strain were performed in parallel. Obvi- 
ously, the data shown in Fig. 4 indicated that the overproduc- 
tion of parvulin also caused an 40-SO-fold increase of PPIase 
activity. The purified parvulin of the overexpression strain was 
composed of the house-keeping level of the enzyme and the 
major amount resulting from the plasmid information. The 
purified protein with a specific activity similar to the wild type 
enzyme showed the same N-terminal sequence as authentic 
parvulin with no indication of a contaminating polypeptide and 
had the same molecular mass of 10,100.66 f 1.64 Da as deter- 
mined by electrospray mass spectrometry. Furthermore, sub- 
strate specificity and avidity to react with polyclonal antibodies 
raised against the wild type parvulin were indistinguishable 
from that of the authentic protein. These results unequivocally 
show that recombinant parvulin is the cyclosporin A and 
FK506-insensitive PPIase previously isolated from wild type 
E. coli. The data also show that parvulin did not represent a 
proteolytic fragment of a larger polypeptide chain and exerts 
its catalytic activity without the help of other factors. With 
respect o molecular size, a polypeptide chain of 92 amino acids 
belongs to the extremes among enzymes. Thus, monomers of 
a tetrameric dihydrofolate reductase have 78 amino acids [13]. 
HIV-l protease with 99 residues performs catalysis as a dimer 
[14] and very small subunits of the 4-oxalocrotonate tautom- 
erase comprising only 62 amino acid residues assemble to a 
pcntameric enzyme [15]. From the pattern of the protein peak 
in gel filtration studies there was no indication for the presence 
of oligomeric parvulin molecules. 
The amino acid sequence of parvulin is very hydrophilic as 
J.-V. Rahfeld et al. IFEBS Letters 352 (1994) 180-184 183 
charged residues make up 28% of the protein. The p1 value, as 
estimated by isoelectric focusing on a pH 5-10 IEF gel, was 
>9.5, approaching the calculated p1 of 9.65. 
Application of the Chou-Fasman-Rose algorithm [17,18] to 
the sequence of parvulin predicted the presence of an extented 
a-helical region of about 30 residues at the N-terminus which 
turned out to have amphiphilic features in the helical wheel 
projection [19], and only few p-sheet. This was confirmed by 
analyzing the far UV-CD spectrum of parvulin with the protein 
secondary structure estimation program SSE-338 (Fig. 5). 
Thus, parvulin was calculated to have 75.8% cc-helix and 10.5% 
p-sheet and 13.8%/3-turn. This is in contrast to human cytosolic 
cyclophilin [20] and human FKBP12 [21,22] the 3D-structure 
of which show much less a-helix and more p-sheet. 
As already expected from the 21 amino acid fragment [4], the 
entire sequence of parvulin did not share convincing similarity 
with either FKBP12cy or cyclophilin 18cy when aligned utiliz- 
ing the BESTFIT program (Fig. 6B). Identities were calculated 
as 12.7% and 23.1%, respectively, with only minor contribu- 
tions of strongly conserved amino acids and introduction of 
several gaps. These data underlined the existence of a PPIase 
unrelated in its primary structure to the members of known 
families of this enzyme class. 
180 200 220 240 260 
h lnml 
Fig. 5. Far UV-CD spectrum of parvulin. The spectrum was monitored 
in 10 mM sodium phosphate, pH 6.5 at 20°C. The protein concentra- 
tion was 0.18 mg/ml. 
Comparison of the sequence of parvulin to sequences con- 
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Fig. 4. Comparison of gel filtration profiles of the purification of au- 
thentic and recombinant parvulin. Samples of 1 ml protein solution 
derived from E. co/i K-12 strain HBlOl (A) and from E. coli K-12 strain 
DHSa with pSEP38 (B) after performing anion exchange chromatogra- 
phy (Fractogel EMD DEAE-650(M)), affinity chromatography (Frac- 
togel TSK AF-Blue) and concentration with a Filtron OMEGACELL, 
500 Da were applied to a HiLoad 16/60 Superdex 75 gel filtration 
column. The gel filtration was performed in 10 mM HEPES buffer, pH 
7.8, containing 150 mM KC1 and 0.5 mM DTT at a flowrate of 
1 mumin. 
tained in the combined protein database (Pir, Mipsown, 
Patchx, Swissprot) by FASTA revealed interesting similarities. 
Three microbial proteins were found to have a highly signifi- 
cant level of identity: PrsA from Bacillus subtilis (43.8%) [23], 
SurA from E. coli (32.0%) [24], and PrtM from Luctococcus 
lactis (26.8%) [25]. Based on the CLUSTAL multiple alignment 
shown in Fig. 6A the percentage of fully conserved residues of 
parvulin (15.2%) allowed to define a family of related proteins 
which may probably exhibit the enzymatic function of PPIases. 
Because the homologous proteins are much larger than par- 
vulin (PrsA, 33 kDa; PrtM, 33.1 kDa and SurA, 47.4 kDa), they 
may contain domains not involved in the suggested PPIase 
activity. The parvulin sequence was found to contain the motif 
DFG (pos. 29-31), the triad required in protein kinases for 
catalysis of phosphate transfer [ 161. We do not know, however, 
whether this has any biological relevance, because this motif is 
not conserved in all of the homologous proteins (Fig. 6A). 
Interestingly, two out of three homologous proteins men- 
tioned above appear to be involved in maturation of proteins. 
In prsd mutants of Bacillus subtilis the level of certain secreted 
exoproteins is decreased by blocking the protecting effect of 
PrsA on events which lead to misfolded proteins [23]. Keeping 
in mind that PPIases are devoid of true chaperone-like ffects 
[26], PPIase activity may also simulate the postulated chaper- 
one capability [27,28] of PrsA by kinetic control of folding 
intermediates. 
A more specific action has been established for the PrtM 
protein of Lactococcus lactis SK1 1, because a serine proteinase 
of the cell wall was produced as inactive precursor in the ab- 
sence of the protein [29]. 
It remains to be seen whether these proteins have indeed 
PPIase activity and thus belong to the same newly identified 
PPIase family as parvulin. 
Acknowledgements: We are grateful to Drs. E.V. Koonin and K.E. 
Rudd for sending a manuscript in advance of publication. We thank 
Fig. 6. (A) Sequence alignment of parvulin from E. coli, PrsA from 
B. subtilis (Accession Number Pir3 : S15269), SurA from E. co/i (Acces- 
sion Number Pir3 : S40574), and PrtM from L. lactis (Accession Num- 
ber Pir2: A32313), as performed by the multiple alignment program 
CLUSTAL. Identities are printed in bold letters and are indicated by 
an asterisk in the last line. Similarities are presented as a period. (B) The 
alignments of the amino acid sequences of E. coli parvulin with 
stretches from human FKBPcy (Accession Number Pir3 : S11089), and 
human cyclophilin A (Accession Number Pirl : CSHUA), as calculated 
using the program BESTFIT are presented. Identities are shown as 1, 
weak and strong similarities as and :, respectively. Residues being 
strongly conserved in FKBPs and cyclophilins are printed in bold 
letters. 
Dr. A. Schierhorn for assistance with the electrospray mass spectrom- 
etry. The work was supported by a grant from the Deutsche 
Forschungsgemeinschaft (Fi 455/l-3), the Fonds der Chemischen In- 
dustrie and the Boehringer-Ingelheim Stiftung. 
References 
PI 
g; 
[41 
Fischer, G. (1994) Angew. Chemie 106, 147991501. 
Galat, A. (1993) Eur. J. Biochem. 216, 689-707. 
Trandinh, C.C., Pao, G.M. and Saier, M.H. (1992) FASEB J. 6, 
3410-3420. 
Rahfeld, J.-U., Schierhorn, A., Mann, K. and Fischer, G. (1994) 
FEBS Lett. 343. 65-69. 
[51 
El 
[71 
181 
191 
DOI 
t111 
1121 
1131 
u41 
1151 
Pf.2 
P71 
[I81 
1191 
PO1 
PII 
PI 
~231 
~241 
v51 
WI 
v71 
VI 
~291 
J.-U. Rahfeld et al. IFEBS Letters 352 (1994) 180-184 
Wiilfing, C., Lombardero, J. and Phickthun, A. (1994) J. Biol. 
Chem. 269, 2895-2901. 
Roof. W.D., Horne, S.M., Young, K.D. and Young, R. (1994) 
J. Biol. Chem. 269, 2902-2910. 
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T. and 
Schmid, F.X. (1989) Nature 337, 476478. 
Sambrook, J., Fritsch, F.E. and Maniatis, T. (1989) Molecular 
Cloning: A Laboratory Manual, Cold Spring Habor Laboratory, 
Cold Spring Habor, NY. 
Hanalian, D. (1983) J. Mol. Biol. 166, 557-580. 
Pearson, W.R. and Lipman, D.J. (1988) Proc. Natl. Acad. Sci. 
USA 85, 24442448. 
Higgins, D.G., Bleasby, A.J. and Fuchs, R. (1992) Comput. Appl. 
Biosci. 8, 1899191. 
Daniels, D., Plunkett III, G., Burland, V.D. and Blattner, F.R. 
(1992) Science 257, 771-778. 
Zolg, J.W. and Hanggi, U.J. (1981) Nucleic Acids Res. 9, 697- 
710. 
Meek, T.D., Dayton, B.D., Metcalf, B.W., Dreyer, G.B., Strichler, 
F.E., Gorniak, J.G., Rosenberg, M., Moore, M.L., Magaard, 
V.W. and Debouck (1989) Proc. Natl. Acad. Sci. USA 86, 1841- 
1845. 
Chen, L.H., Kenyon, G.L., Curtin, F., Harayama, S., Bembenek, 
M.E., Hajipour, G. and Whitman, C.P. (1992) J. Biol. Chem. 267, 
1771&17721. 
Kemp, B.E. and Pearson, R.B. (1990) Trends Biochem. Sci. 15, 
342-346. 
Chou, P.Y. and Fasman, G.D. (1978) Annu. Rev. Biochem. 47, 
351-276. 
Rose, G.D. (1978) Nature 272, 586590. 
Schiffer, M. and Edmundson, A.B. (1967) Biophys. J. 7, 121-135. 
Ke, H. (1992) J. Mol. Biol. 228, 539-550. 
Michnick, S.W., Rosen, M.K., Wandless, T.J., Karplus, M. and 
Schreiber, S.L. (1991) Science 252, 836839. 
Meadows, R.P., Nettesheim, D.G., Xu, R.X., Olejniczak, E.T., 
Petros, A.M., Holzman, T.F., Severin, J., Gubbins, E., Smith, H. 
and Fesik, SW. (1993) Biochemistry 32, 754765. 
Kontinen, V.P., Saris, P. and Sarvas, M. (1991) Mol. Microbial. 
5, 1273-1283. 
Yura, T., Mori, H., Nagai, H., Nagata, T., Ishihama, A., Fujita, 
N., Isono, K., Mizobuchi, K. and Nakata, A., submitted to the 
EMBL Data Library, December 1992. 
Haandrikman, A.J., Kok, J., Laan, H., Soemitro, S., Ledeboer, 
A.M., Konings, W.N. and Venema, G. (1989) J. Bacterial. 171, 
278992794. 
Kern, G., Kern, D., Schmid, F.X. and Fischer, G. (1994) FEBS 
Lett. 348, 1455148. 
Jacobs, M., Andersen, J.B., Kontinen, V. and Sarvas, M. (1993) 
Mol. Microbial. 8, 957-966. 
Kontinen, V.P. and Sarvas, M. (1993) Mol. Microbial. 8,727-737. 
Vos, P. and van Asseldonk, M. (1989) J. Bacterial. 171, 27955 
2802. 
